Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

BACKGROUND: Although angiotensin receptor blockers have different receptor binding properties, no comparative randomized studies with cardiovascular event endpoints have been performed for this class of drugs. The aim of this study was to assess the long-term cost-effectiveness of candesartan (Ataca...

Descripción completa

Detalles Bibliográficos
Autores principales: Granström, Ola, Levin, Lars-Åke, Henriksson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493257/
https://www.ncbi.nlm.nih.gov/pubmed/23144565
http://dx.doi.org/10.2147/CEOR.S35824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493257/
https://www.ncbi.nlm.nih.gov/pubmed/23144565
http://dx.doi.org/10.2147/CEOR.S35824

Ejemplares similares